Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04820387 · ClinicalTrials.gov registry record

Assessment of Remote Vital Signs for Telemedicine Applications

A clinical trial of Telemedicine and Physiology, sponsored by Johns Hopkins University.

Active
Registry status
94
Enrollment target
1
Study location

NCT04820387: Active study of Telemedicine and Physiology, sponsored by Johns Hopkins University.

NCT04820387 is a study of Telemedicine and Physiology that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 94 participants, below the 4,052-participant average among 18 other Telemedicine trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04820387, a study of Telemedicine and Physiology, is active but no longer recruiting, sponsored by Johns Hopkins University.

ACTIVE NOT RECRUITING
Registry status
94 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether vital signs can be extracted from video. A secondary purpose is to create a database, including raw video, of "ground truth" physiological data on human subjects in order to test current and/or future approaches developed to extract vital signs from video. This research may have an immediate impact on not only the assessment of risk for COVID-19 but also may provide a significant technological enhancement to Johns Hopkins Medicine's telemedicine capabilities.

Primary Outcome

The principal outcome is the capability to calculate a reliable and clinically useful measure of blood oxygenation from video. Our objective is to quantify SpO2 from video within +/- 0.5% from clinical standard.

Conditions Studied

Study Locations (1)

Maryland

  • Johns Hopkins Asthma & Allergy Center - Baltimore

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2021-04-20
Est. Completion 2026-12
Johns Hopkins University

1,448 total trials

What the registry record for NCT04820387 still lists

NCT04820387 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 4,052-participant average among 18 other Telemedicine trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Telemedicine appearing as the primary indexed condition, and to 0 interventions.

NCT04820387 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT04820387 about?

NCT04820387 is a clinical study titled "Assessment of Remote Vital Signs for Telemedicine Applications". The purpose of this study is to determine whether vital signs can be extracted from video. A secondary purpose is to create a database, including raw video, of "ground truth" physiological data on human subjects in order to test current and/or future approaches developed to extract vital signs from ...

What is the current status of trial NCT04820387?

This trial is currently active not recruiting. The enrollment target is 94 participants. The study started on 2021-04-20. Estimated completion is 2026-12.

What conditions does trial NCT04820387 study?

This clinical trial studies the following conditions: Telemedicine, Physiology.

Who is sponsoring clinical trial NCT04820387?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04820387 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Telemedicine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04820387's enrollment target sits among peer trials

94 16th of 18 higher than 3 of 18 other Telemedicine trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Telemedicine trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03747146 · 94 participants · NA

    Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service

  • NCT04061421 · 94 participants · Phase 1

    Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)

  • NCT04205968 · 94 participants · Phase 2

    Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

  • NCT04464759 · 94 participants · Phase 1

    A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04820387, the US trial registry maintained by the National Library of Medicine. NCT04820387 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.